Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-28

FDA Approved: BETAINE ANHYDROUS — Original Application (Eton Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved an original generic application for betaine anhydrous, manufactured by Eton Pharmaceuticals. It is indicated for the treatment of homocystinuri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BETAINE ANHYDROUS (betaine anhydrous)

Snippet

ORIG AP for BETAINE ANHYDROUS (BETAINE ANHYDROUS)